{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:47:08Z","timestamp":1767847628690,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.vaccine.2021.08.100","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T07:34:12Z","timestamp":1631518452000},"page":"6074-6080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Validation of algorithms using International Classification of Diseases for the identification of herpes zoster episodes requiring hospitalization in Quebec, Canada"],"prefix":"10.1016","volume":"39","author":[{"given":"\u00c8ve","family":"Capistran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Morin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Marcoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Trudel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micheline","family":"Gagn\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Proulx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Nour Abou Chakra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Gagnon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Carignan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.08.100_b0005","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/infdis\/jit405","article-title":"Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005\u20132009","volume":"208","author":"Weinmann","year":"2013","journal-title":"J Infect Dis."},{"key":"10.1016\/j.vaccine.2021.08.100_b0010","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz","year":"2008","journal-title":"MMWR Recomm Rep."},{"key":"10.1016\/j.vaccine.2021.08.100_b0015","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/cid\/ciy953","article-title":"The epidemiology of herpes zoster in the United States during the era of varicella and herpes zoster vaccines: changing patterns among older adults","volume":"69","author":"Harpaz","year":"2019","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.vaccine.2021.08.100_b0020","doi-asserted-by":"crossref","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open."},{"key":"10.1016\/j.vaccine.2021.08.100_b0025","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1017\/S0950268800004714","article-title":"Modelling the impact of immunization on the epidemiology of varicella zoster virus","volume":"125","author":"Brisson","year":"2000","journal-title":"Epidemiol Infect."},{"issue":"2","key":"10.1016\/j.vaccine.2021.08.100_b0030","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/cid\/ciw296","article-title":"Increasing incidence of herpes zoster over a 60-year period from a population-based study","volume":"63","author":"Kawai","year":"2016","journal-title":"Clin Infect Dis."},{"issue":"12","key":"10.1016\/j.vaccine.2021.08.100_b0035","article-title":"The burden of varicella and zoster in British Columbia 1994\u20132003: baseline assessment prior to universal vaccination","volume":"33","author":"Edgar","year":"2007","journal-title":"Canada Commu Dis Rep."},{"issue":"47","key":"10.1016\/j.vaccine.2021.08.100_b0040","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1016\/j.vaccine.2011.09.024","article-title":"Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program","volume":"29","author":"Tanuseputro","year":"2011","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2021.08.100_b0045","unstructured":"Gouvernement du Qu\u00e9bec. MED-\u00c9CHO - Hospitalisations et chirurgies d'un jour dans les centres hospitaliers du Qu\u00e9bec. https:\/\/www.msss.gouv.qc.ca\/professionnels\/statistiques-donnees-services-sante-services-sociaux\/med-echo-hospitalisations-et-chirurgies-d-un-jour-dans-les-centres-hospitaliers-du-quebec\/. Accessed September 4 2020."},{"issue":"9","key":"10.1016\/j.vaccine.2021.08.100_b0050","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/aje\/kwr206","article-title":"Comparing shingles incidence and complication rates from medical record review and administrative database estimates: how close are they?","volume":"174","author":"Yawn","year":"2011","journal-title":"Am J Epidemiol."},{"key":"10.1016\/j.vaccine.2021.08.100_b0055","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/INF.0000000000001040","article-title":"Positive predictive value of ICD-9 code for herpes zoster among children during the varicella vaccine era","volume":"35","author":"Weinmann","year":"2016","journal-title":"Pediatr Infect Dis J."},{"issue":"12","key":"10.1016\/j.vaccine.2021.08.100_b0060","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1086\/430325","article-title":"Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992\u20132002","volume":"191","author":"Jumaan","year":"2005","journal-title":"J Infect Dis."},{"key":"10.1016\/j.vaccine.2021.08.100_b0065","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1186\/1471-2334-13-463","article-title":"Herpes zoster surveillance using electronic databases in the Valencian Community (Spain)","volume":"13","author":"Morant-Talamante","year":"2013","journal-title":"BMC Infect Dis."},{"issue":"3","key":"10.1016\/j.vaccine.2021.08.100_b0070","doi-asserted-by":"crossref","first-page":"103","DOI":"10.15585\/mmwr.mm6703a5","article-title":"Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines","volume":"67","author":"Dooling","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"5","key":"10.1016\/j.vaccine.2021.08.100_b0075","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis."},{"key":"10.1016\/j.vaccine.2021.08.100_b0080","unstructured":"Minist\u00e8re de la Sant\u00e9 et des Services Sociaux du Qu\u00e9bec. SIGDU - Syst\u00e8me d'information de gestion des urgences. 2018. https:\/\/www.msss.gouv.qc.ca\/professionnels\/technologies-de-l-information\/actifs-informationnels\/sigdu\/. Accessed September 4 2020."},{"key":"10.1016\/j.vaccine.2021.08.100_b0085","unstructured":"Bureau d'information et d'\u00e9tudes en sant\u00e9 des population. Le BIESP en un coup d'oeil. 2018. https:\/\/inspq.qc.ca\/gestion-et-analyse-de-l-information\/le-biesp. Accessed September 4 2020."},{"issue":"36","key":"10.1016\/j.vaccine.2021.08.100_b0090","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1016\/j.vaccine.2019.07.086","article-title":"The changing epidemiology of herpes zoster over a decade in South Korea, 2006\u20132015","volume":"37","author":"Choi","year":"2019","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2021.08.100_b0095","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1186\/s12879-016-1898-z","article-title":"Increasing incidence associated with herpes zoster infection in British Columbia","volume":"16","author":"Marra","year":"2016","journal-title":"Canada. BMC Infect Dis."},{"key":"10.1016\/j.vaccine.2021.08.100_b0100","unstructured":"Comit\u00e9 sur l\u2019immunisation du Qu\u00e9bec. Avis sur la pertinence d\u2019ajouter la vaccination contre le zona au Programme qu\u00e9b\u00e9cois d\u2019immunisation. https:\/\/www.inspq.qc.ca\/publications\/2381 Accessed September 4 2020."},{"key":"10.1016\/j.vaccine.2021.08.100_b0105","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12879-015-1059-9","article-title":"Burden of herpes zoster: the direct and comorbidity costs of herpes zoster events in hospitalized patients over 50 years in France","volume":"15","author":"Blein","year":"2015","journal-title":"BMC Infect Dis."},{"key":"10.1016\/j.vaccine.2021.08.100_b0110","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1186\/s12879-017-2688-y","article-title":"Hospitalizations realted to herpes zoster infection in the Canary Islands, Spain (2005\u20132014)","volume":"17","author":"Garc\u00eda-Rojas","year":"2017","journal-title":"BMC Infect Dis."},{"key":"10.1016\/j.vaccine.2021.08.100_b0115","unstructured":"Institut de la statistique du Qu\u00e9bec. Banque de donn\u00e9es des statistiques officielles sur le Qu\u00e9bec. https:\/\/bdso.gouv.qc.ca\/pls\/ken\/Ken211_Page_Accu.page_accu. Accessed September 4 2020."},{"key":"10.1016\/j.vaccine.2021.08.100_b0120","unstructured":"Statistics Canada. Canadian standard population, 1991. 2015. https:\/\/www150.statcan.gc.ca\/n1\/pub\/82-003-x\/2013008\/article\/11857\/tbl\/appa-eng.htm. Accessed September 4 2020."},{"issue":"2","key":"10.1016\/j.vaccine.2021.08.100_b0125","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5021\/ad.2018.30.2.253","article-title":"Validation of herpes zoster diagnosis code in the electronic medical record: a retrospective, multicenter study","volume":"30","author":"Kim","year":"2018","journal-title":"Ann Dermatol."},{"issue":"6","key":"10.1016\/j.vaccine.2021.08.100_b0130","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1017\/S0950268807007893","article-title":"Secular trends in the epidemiology of shingles in Alberta","volume":"135","author":"Russell","year":"2007","journal-title":"Epidemiol Infect."},{"issue":"4","key":"10.1016\/j.vaccine.2021.08.100_b0135","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s15010-014-0645-x","article-title":"Risk of herpes zoster among diabetics: a matched cohort study in a US insurance claim database before introduction of vaccination, 1997\u20132006","volume":"42","author":"Guignard","year":"2014","journal-title":"Infection"},{"key":"10.1016\/j.vaccine.2021.08.100_b0140","article-title":"Quantification of risk factors for herpes zoster: population based case-control study","volume":"348","author":"Forbes","year":"2014","journal-title":"BMJ"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21011622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21011622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:02:03Z","timestamp":1759402923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21011622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":28,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0264410X21011622"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.100","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of algorithms using International Classification of Diseases for the identification of herpes zoster episodes requiring hospitalization in Quebec, Canada","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}